4,4′-Diaminodiphenyl sulfone (Dapsone) CAS: 80-08-0
Dapsone magani ne mai amfani da yawa wanda ake amfani da shi wajen magance cututtuka da dama na fata saboda tasirinsa na maganin ƙwayoyin cuta da kuma hana kumburi. Ana yawan rubuta shi don maganin kuturta (cutar Hansen), wata cuta mai yaduwa ta yau da kullun da Mycobacterium leprae ke haifarwa wadda ke shafar fata da jijiyoyi. Dapsone kuma yana da tasiri wajen magance dermatitis herpetiformis, wata cuta mai kumburi ta fata mai tsanani da ke da alaƙa da cutar celiac. Baya ga waɗannan manyan alamu, ana iya amfani da Dapsone ba tare da lakabi ba don magance wasu cututtukan fata kamar kuraje vulgaris, bullous pemphigoid, da cutaneous lupus erythematosus. Ana samun maganin a cikin nau'in kwamfutar hannu da shirye-shiryen shafawa, wanda ke ba wa masu samar da lafiya damar daidaita tsarin magani bisa ga buƙatun majiyyaci da tsananin cutar. Marasa lafiya da ke shan maganin Dapsone ya kamata su bi umarnin mai ba su lafiya a hankali game da yawan allurai, tsawon lokacin magani, da kuma illolin da ka iya tasowa. Kulawa akai-akai na ƙididdigar jini da gwaje-gwajen aikin hanta na iya zama dole don tabbatar da amfani da magani lafiya da gano mummunan sakamako da wuri. Yana da mahimmanci ga marasa lafiya su sanar da mai ba su kulawa duk wata damuwa ko canje-canje a yanayinsu yayin maganin Dapsone don inganta sakamakon magani da kuma rage haɗarin rikitarwa. Ta hanyar bin tsarin da aka tsara da kuma ci gaba da sadarwa a fili da ƙungiyar kula da lafiyarsu, marasa lafiya za su iya amfana daga tasirin maganin Dapsone wajen magance cututtuka daban-daban na fata yadda ya kamata.
| Tsarin aiki | C12H12N2O2S |
| Gwaji | 99% |
| Bayyanar | farin foda |
| Lambar CAS | 80-08-0 |
| shiryawa | Ƙarami da girma |
| Rayuwar shiryayye | Shekaru 2 |
| Ajiya | A adana a wuri mai sanyi da bushewa |
| Takardar shaida | ISO. |








![2-((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanoloxalate CAS:1402150-30-4](https://cdn.globalso.com/xindaobiotech/@LXIVIBPRLO53RUL5FBL7H716.png)